THE NATIONAL CANCER INSTITUTE REGINA ELENA, IN COLLABORATION WITH EUROFINS GENOMA GROUP LABORATORIES, SHOWS HOW LIQUID BIOPSY IN COLON CANCER CAN PROVIDE COMPLEMENTARY ANSWERS TO THOSE OF OTHER BIOLOGICAL TESTS AND IMPROVE THE CURRENT DIAGNOSTIC STRATEGIES.
Early diagnosis of colorectal carcinoma is a need deeply felt by both patients and health authorities. Many patient rights associations (eg Digestive Cancers Europe; https://www.digestivecancers.eu) have long been pressing for new and more accurate diagnostic tests to be adopted in clinical practice. Liquid Biopsy is one of these tests, and is based on the detection […]